The Desmond Tutu
HIV Foundation

Pairing rigorous research with community-driven development, the DTHF is making a substantial contribution to service delivery and public health policy relating to HIV, tuberculosis and related infections in South Africa.

About Us Our People

HIV weekly news update in partnership with MedicalBrief

  • MEDICALBRIEF Issue No 0192 – HIV News 22 February 2018

    Darunavir/ritonavir for ART-experienced patients

    Darunavir/ritonavir is the most durable boosted protease inhibitor for antiretroviral (ART)-experienced patients, investigators from the EuroSIDA cohort report.
  • MEDICALBRIEF Issue No 0192 – HIV News 22 February 2018

    Death rates of Zambians on ART underestimated up to ninefold

    People with HIV in Zambia were at least ten times more likely to die in the first two years after starting antiretroviral treatment (ART) than European patients.
  • MEDICALBRIEF Issue No 0191 – HIV News 15 February 2018

    FDA approves new single tablet ARV containing the HIV integrase inhibitor bictegravir

    Bictegravir is combined with two nucleoside/nucleotide reverse transcriptase inhibitors: emtricitabine and tenofovir alafenamide (TAF), the new kidney- and bone-friendly formulation of tenofovir.
  • MEDICALBRIEF Issue No 0191 – HIV News 15 February 2018

    Interpersonal psychotherapy delivered to HIV patients telephonically

    Tele-interpersonal psychotherapy provides longer-term depression relief in depressed rural people living with HIV.
  • MEDICALBRIEF Issue No 0190 – HIV News 08 February 2018

    Perinatal safety outcomes with atazanavir and darunavir

    Atazanavir and darunavir, two HIV protease inhibitors commonly used during pregnancy, have similar safety and activity profiles.
View All

Our Research


Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines.

Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) based at the University of Cape Town and the Desmond Tutu …
Read More

Measuring Early Treatment Adherence (META) Study: What We Found

The DTHF team at the Gugulethu Research Offices (GRO) under the direction of local Principal Investigator, Assoc Professor Catherine Orrell, …
Read More

20,000 Moments Condoms Donated to Women of Worth

Many young South Africans do not know that contraceptives are available. The shipment of more than 20 000 Coral Healthcare condoms has …
Read More

Apply for the Mark Wainberg Fellowship Opportunity for Clinicians

The Mark Wainberg Fellowship Programme: Experts in HIV Service Delivery is a two-year fellowship for five sub-Saharan African clinicians. This …
Read More

Our Projects

Desmond Tutu HIV Centre: Postgraduate Diploma in TB-HIV Medicine

Overview The Desmond Tutu HIV Centre and the University of Cape Town are proud to present the first online postgraduate …
Read More

The Tutu Tester

HIV and TB are managed successfully in many countries around the world. Yet, millions of people are still missing care. …
Read More

Adult HIV Educational Programme

Order a Manual Free Online Manual The aim of the HIV education programme is to improve the care of men …
Read More


Youth Centre
Youth Centre

The DTHF Youth Centre

The DTHF Youth Centre complex in Masiphumelele was built in response to requests from the community for a safe, recreational space for young people. DTHF surveys record a high prevalence of HIV infection among youth in the community.

Visit the Youth Centre